Key Insights

Highlights

Treatment Research

2 treatments under study, led by Sulfur Hexafluoride Lipidtype A Microspheres

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Terminated1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Sulfur Hexafluoride Lipidtype A Microspheres1
  • Bms Vs Cs1

Active Sponsors

  • University of Copenhagen1
  • Bracco Diagnostics, Inc1
  • Children's Hospital of Philadelphia1
  • Copenhagen University Hospital, Rigshospitalet1

Top Investigators

Related Conditions

  • Stentgraft Restenosis1
  • Stent Occlusion1
  • Stentgraft Thrombosis1
  • Superior Mesenteric Atherosclerosis1
  • Stent Thrombosis1

Activity Timeline